MustGrow BiologicsMGROF 29 Net Current Asset Value is $0.02 as of Mar. 2026, which is 100% below its 10-year median of 22.48. GuruFocus rates MGROF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review. Among 162 Agriculture companies, MustGrow Biologics ranks worse than 87.65% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
MustGrow Biologics's net current asset value per share for the quarter that ended in Mar. 2026 was $0.02.
The historical rank and industry rank for MustGrow Biologics's Net Current Asset Value or its related term are showing as below:
MGROF'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 5.71 Med: 22.48 Max: 66
Current: 27.38
During the past 10 years, the highest Price-to-Net-Current-Asset-Value Ratio of MustGrow Biologics was 66.00. The lowest was 5.71. And the median was 22.48.
MGROF's Price-to-Net-Current-Asset-Value is ranked worse than 87.65% of 162
companies
in the Agriculture industry
Industry Median: 3.6
vs MGROF: 27.38
MustGrow Biologics (OTCPK:MGROF) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
MustGrow Biologics Net Current Asset Value Related Terms
MustGrow Biologics Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MGROF vs CTVA, CF, MOS: Net Current Asset Value Comparison
For the Agricultural Inputs subindustry, MustGrow Biologics's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics Price-to-Net-Current-Asset-Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.02 mean?
MustGrow Biologics (MGROF) has a Net Current Asset Value of $0.02 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on MustGrow Biologics and its competitors. This is 100% below median its historical median of 22.48. Over the past decade, MustGrow Biologics' Net Current Asset Value has ranged from 5.71 to 66.00. According to the industry distribution chart, MustGrow Biologics ranks #142 out of 162 companies in the Agriculture industry, placing it in the top 87.7%.
Is MustGrow Biologics' Net Current Asset Value too high?
MustGrow Biologics' current Net Current Asset Value of $0.02 is 100% below median its 10-year median of 22.48. Over the past 10 years, this metric has ranged from a low of 5.71 to a high of 66.00. The Agriculture industry median Net Current Asset Value is 3.60. MustGrow Biologics' value of $0.02 is 99.4% below this industry median. Based on the distribution chart, MustGrow Biologics ranks #142 out of 162 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, MustGrow Biologics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Net Current Asset Value compare to CTVA and CF?
According to the Agriculture industry distribution chart, MustGrow Biologics ranks #142 out of 162 companies for Net Current Asset Value. This places MustGrow Biologics in the lower half of its industry. The industry median Net Current Asset Value is 3.60. MustGrow Biologics' value of $0.02 is 99.4% below this benchmark. Historically, MustGrow Biologics' own Net Current Asset Value has ranged from 5.71 to 66.00 over the past decade. While the company's 10-year median is 22.48 vs. the industry median of 3.60, MustGrow Biologics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for an Agriculture company?
The median Net Current Asset Value among Agriculture companies is 3.60, based on 162 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MustGrow Biologics's current Net Current Asset Value of $0.02 is 99.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on MustGrow Biologics and its competitors. For the Agriculture industry, the median Net Current Asset Value is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MustGrow Biologics's current Net Current Asset Value is $0.02, which is 100% below median its own 10-year median of 22.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current Net Current Asset Value of $0.02. The current Net Current Asset Value is $0.02, which is 100% below median its 10-year median of 22.48 and 99.4% below the Agriculture industry median of 3.60. MustGrow Biologics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current Net Current Asset Value is $0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
29GF Score
Get the complete analysis for MGROF
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGROF has been successfully added to your 
